In the course of our screening for new antibacterials from microbial metabolites, two new dioxopiperazine metabolites, glioperazines B (1) and C (2), together with the known compound, glioperazine (3), were isolated from the mycelia of a liquid fermentation culture of the fungus, Bionectra byssicola F120. The structures of compounds 1 and 2 were assigned on the basis of MS and NMR data. Compound 1 is an unusual dioxopiperazine metabolite containing an OMe group at thecarbon of the amino acid residue. Compound 1 showed weak antibacterial activity against various strains of S. aureus, including methicillin-resistant S. aureus (MRSA) and quinolone-resistant S. aureus (QRSA), while 2 and 3 did not show such activity.
Gram-positive eubacteria are representative of pathogenic microorganisms. In particular, Staphylococcus aureus is clinically the most important of these pathogens because of its exceptional virulence, stress tolerance, and capacity to induce antimicrobial resistance. 1) Methicillin-resistant S. aureus (MRSA) is known as a major nosocomial pathogen that has also developed resistance to many other antibiotics. Moreover, MRSA has been reported to acquire resistance to the antibiotic of last resort, vancomycin.
2) It has been suggested that S. aureus will acquire full resistance to vancomycin in the near future. Therefore, it is increasingly important and necessary to find new classes of antibacterials.
Results
In the course of our screening for new antibacterials from microbial metabolites, we have previously isolated bionectins A-C, 3) unique monomeric epidithiodioxopiperazines with an indole ring, and verticillin G, 4) dimeric epidithiodioxopiperazine containing a hydrodisulfide group. Further investigation of the polar metabolites of Bionectra byssicola has resulted in the isolation of two new dioxopiperazines, named glioperazines B (1) and C (2), together with the known compound, glioperazine (3) 5) (Fig. 1) . Compound 1 is a rare dioxopiperazine metabolite containing an OMe group at the -carbon of an amino acid residue like diatretol 6) and polanrazines. 7) Compound 2 is reported for the first time in this study as a natural compound, since cyclo-L-Trp-L-Thr has been synthesized as an intermediate in the synthesis of tryptophan-dehydrobutyrine dikeopiperazines. 8) Glioperazine (3) has been reported as a cytotoxic metabolite from Gliocladium sp. In this paper, we report the fermentation, isolation, structural determination and antibacterial activity of 1-3.
Fungal strain F120 was isolated from soil collected in Chungnam Province of South Korea. The EtOAc extract of the mycelia of a liquid fermentation culture of strain F120 was fractionated by silica gel chromatography. Final separation of the active fraction by reversed-phase HPLC afforded two new compounds (1 and 2), together with the known compound, glioperazine (3).
5)
The 1 H-and 13 C-NMR spectroscopic data of 3, together with its molecular weight suggested this compound to be a member of the dioxopiperazine class. Interpretation of the 1 H-and 13 C-NMR data (Table 1 ) led to the identification of 3 as glioperazine. 5) The [] value (+50.9, c 0.11, CHCl 3 ) of 3 is almost identical 6 .70 and 8.51). These spectroscopic data for 1 were similar to those for 3. The major differences were that the 1 H and 13 C chemical shifts of one of two S-methyls of 3 were downfieldshifted from H 2.40 and C 14.6 to H 3.25 and C 51.7, respectively, and the 13 C chemical shift of one of two sp 3 quaternary carbons of 3 was also downfield-shifted from 68.0 to 87.4 in 1. These data suggested the presence of one S-methyl and one O-methyl in 1, instead of the two S-methyls in 3. The position of the S-methyl and O-methyl groups was determined by the HMBC spectrum (Fig. 2) . The O-methyl protons at 3.25 were long-range coupled to the sp 3 quaternary carbon at 87.4 (C-6), which was in turn long-range coupled with the methylene proton at 3.43 (H b -7) and the exchangeable proton at 6.70 (NH-2). On other hand, the Smethyl proton at 2.11 showed HMBC correlation with the sp 3 quaternary carbon at 68.9 (C-3), which was in turn long-range coupled with the methyl protons at 1.22 (H 3 -9) and the exchangeable proton at 6.04 (NH-5). The remaining structure was also confirmed by the HMBC spectroscopic data (Fig. 2) . Thus, the planar structure of 1 was assigned as a new derivative of glioperazine, 3 in which an O-methyl is attached at C-6 instead of a S-methyl. The relative configuration of 1 was determined from the NOESY (Fig. 3) and 1 H-NMR data. NOE between H 3 -9 and 6-OMe was observed, while no NOE between H 3 -9 and 3-SMe was detected. Also, the 3-SMe signal showed NOEs with H-4 0 of the indole ring. These data indicate that the C-8-C-9 side chain and the indole side chain on the dioxopiperazine ring had a trans configuration. This is different from the cis configuration of 3. This different configuration between 1 and 3 was also supported by 1 H-NMR data showing the large difference in 1 H chemical shifts between their C-9 methyl groups ( Table 1 ). The C-9 methyl of 1 was observed in the normal field (1.22 ppm), while that of 3 was in an extraordinarily high field (À0:11 ppm) which could have been due to the anisotrophic effect of the indole ring. H-4 0 showed NOEs with both NH-5 and 3-SMe, suggesting that the C-6-C-3 0 bond was free to rotate. Thus, 1 was determined to be as shown in Fig. 1 (Table 1 ) revealed signals similar to those of 1. The major differences between those compounds were that two methines ( 3.66; 60.6 and 4.12; and 55.1) attributable to the -carbon of an amino acid appeared in 2 instead of the signals for O-methyl, S-methyl, and two sp 3 quaternary carbons in 1. These spectroscopic data suggested that both the two O-methyl and S-methyl of 1 had disappeared in 2. This structure was further corroborated by the HMBC spectrum. One methine proton at 3.66 (H-3) was long-range coupled with two amide carbonyl carbons at 167.2 (C-4) and 169.0 (C-1), the hydrogenated methine carbon at 68.3 (C-8), and the methyl carbon at 19.0 (C-9). Also, the other methine proton at 4.12 (H-6) was long-range coupled with the two amide carbonyl carbons (C-4 and C-1), the methylene carbon at 31.1 (C-7), and the sp 2 quaternary carbon at 109.1 (C-3 0 ). The remaining structure was also confirmed by the HMBC spectroscopic data. Thus, the planar structure of 2 was assigned to be that of a new derivative of glioperazine, 5) in which the S-methyls were detached. The relative configuration of 2 was examined by using the NOESY and 1 H-NMR spectral data. H 3 -9 showed no NOEs with H-3 and H 2 -7, while it had NOE with H-8, like 1. The 1 H chemical shift of the C-9 methyl group was also similar to that of 1. These spectroscopic data indicated that 2 had the same relative configuration as that of 1.
Compound 1 is a new dioxopiperazine metabolite containing OMe at its -carbon. Dioxopiperazines are common secondary metabolites produced by a variety of microorganisms. However, dioxopiperazines containing OH/OR groups at the -carbon of the amino acid residue are rare metabolites, since only two, diatretol 6) and polanrazines, 7) have so far been reported. Diatretol (3-methoxy, 6-hydroxy-cyclo-Phe-Leu) has been isolated from the fungus, Cliotocybe diatreta, exhibited low antibacterial activity against Bacillus, and inhibited the growth germination of Lepidium sativum.
6) Polanrazines containing OH/OMe/SMe groups at the -carbon of cyclo-L-Val-L-Trp have been isolated from the phytopathogenic fungus, Phoma lingam, and polanrazines C and E showed moderate but selective phytotoxicity toward brown mustard leaves, with no damage to white mustard leaves. 7) Compound 1 exhibited time-dependent antibacterial activity against S. aureus. Compound 1 inhibited the cell growth of S. aureus up to at least 10 hr with an MIC value of 50 mg/ml. However, the antibacterial activity of 1 had disappeared after 24 hr. Compound 1 also showed similar antibacterial activity against methicillin-resistant S. aureus (MRSA) and quinolone-resistant S. aureus (QRSA) with an MIC value of 50 mg/ml, while oxacillin and norfloxacin, as controls, didn't exhibit any antibacterial activity toward MRSA and QRSA, respectively, even at 200 mg/ml (Table 2) . Compounds 2 and 3, however, showed no antibacterial acitvity even at 200 mg/ml. These data suggest that the O-methyl at C-6 might be related to the antibacterial activity of 1. Interestingly, this relationship is in some agreement with the phytotoxic activity of polanrazines, in which polanrazines C and E with an OH group at C-6 were active, while polanrazines A, B, D and E with SMe or H groups at C-6 were inactive. 7) In conclusion, 1 is a rare dioxopiperazine metabolite containing an OMe group at its -carbon. Compound 1 inhibited the cell growth of various strains of S. aureus, including methicillin-resistant S. aureus (MRSA) and quinolone-resistant S. aureus (QRSA), with an MIC value of 50 mg/ml. Neither 2 nor 3, however, showed any antibacterial activity. Compound 2 is reported as a new metabolite for the first time in this study.
Experimental
General. Optical rotation data were determined by a JASCO P-1020 polarimeter. UV spectra were measured with a Shimadzu UV-1601 UV-visible spectrophotometer. IR spectra were obtained with a Bruker Equinox 55 spectrophotometer. NMR spectra were recorded with a Bruker Biospin Avance 500 spectrometer. HREIMS and HRFABMS data were recorded with a Jeol JMS-700 MSTATION mass spectrometer. Column chromatography on silica gel (Kieselgel 60, 70-230 mesh, Merck) and thin-layer chromatography on pre-coated silica gel 60 F 254 (0.25 mm, Merck) were carried out. HPLC was performed by a Waters system, using a reversed-phase ODS column (YMC C 18 , 10 Â 250 mm).
The F120 fungal strain was isolated from a soil sample collected in Fermentation and isolation. Fermentation was carried out in a liquid culture medium containing a YPS medium (2% glucose, 0.2% yeast extract, 0.5% peptone, 0.05% MgSO 4 , and 0.1% KH 2 PO 4 at pH 5.7 before sterilization). A piece of strain F120 from a mature plate culture was inoculated into a 500-ml Erlenmeyer flask containing 80 ml of the foregoing sterile liquid medium and cultured on a rotary shaker (150 rpm) at 28 C for 3 days. For the production of active compounds, 15 ml of the seed culture was transferred into 1000-ml Erlenmeyer flasks containing 300 ml of the YPS medium, and cultivated on a rotary shaker (150 rpm) for 7 days at 28 C. After incubation, the fermented liquid culture (73 liter) was centrifuged at 6000 rpm for 20 min, and then the mycelial parts were extracted with 80% acetone. The acetone extract was concentrated in vacuo to an aqueous solution, which was then extracted three times with an equal volume of EtOAc. The EtOAc extract (5 g) was subjected to silica gel column chromatography, using stepwise elution with CHCl 3 -MeOH (100:1 5 ½ D +52.6 (c 0.11, CHCl 3 )]; 1 H-, and 13 C-NMR, and MS data were in accordance with those for glioperazine.
5)
Determination of antibacterial susceptibility. 9) S. aureus RN4220, two MRSA strains (CCARM3167 and CCARM3506), and two QRSA strains (CCARM 3505 and CCARM 3519) were used. S. aureus was grown to the mid-log phase in Mueller-Hinton broth and diluted 1,000-fold in the same medium. Cells (10 5 /ml) were inoculated into the Mueller-Hinton broth and dispensed at 0.2 ml/well into a 96-well microtiter plate. MICs were determined in triplicate by serial dilution of the test compounds. MIC is defined as the concentration of a test compound that completely inhibited cell growth at 30 C. Bacterial growth was determined by measuring the absorption at 650 nm, using a microtiter ELISA reader.
